Authors: Slatter, JG Schaaf, HJ Sams, JP Feenstra, KL Johnson, MG Bombardt, PA Cathcart, KS Verburg, MT Pearson, LK Compton, LD Miller, LL Baker, DS Pesheck, CV Lord, RS

Citation: Jg. Slatter et al., Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following i.v. infusion of [C-14]CPT-11 in cancer patients, DRUG META D, 28(4), 2000, pp. 423-433

Authors: Fleishaker, JC Herman, BD Pearson, LK Ionita, A Mucci, M

Citation: Jc. Fleishaker et al., Evaluation of the potential pharmacokinetic/pharmacodynamic interaction between fluoxetine and reboxetine in healthy volunteers, CLIN DRUG I, 18(2), 1999, pp. 141-150

Authors: Fleishaker, JC Pearson, LK Knuth, DW Gomez-Mancilla, B Francom, SF McIntosh, MJ Freestone, S Azie, NE

Citation: Jc. Fleishaker et al., Pharmacokinetics and tolerability of a novel 5-HT1D agonist, PNU-142633F, INT J CL PH, 37(10), 1999, pp. 487-492

Authors: Fleishaker, JC Pearson, LK Pearson, PG Wienkers, LC Hopkins, NK Peters, GR

Citation: Jc. Fleishaker et al., Hormonal effects on tirilazad clearance in women: Assessment of the role of CYP3A, J CLIN PHAR, 39(3), 1999, pp. 260-267